At the upcoming DIA 2018 meeting, Tufts Center for the Study of Drug Development will preview its study findings on the root causes for delays and inefficiencies impacting trial timelines. Through this study, Tufts spoke with executives to learn about the top challenges and opportunities in clinOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.